A Novel Inhibitor to an Essential Protein SMNDC1 Could Unlock New Treatments for ALS
A new inhibitor for an essential protein, SMNDC1, has been discovered by researchers at the University of Oxford. This protein plays a critical role in the development of nerve cells, and the new inhibitor could hold potential for treating neurological disorders. The inhibitor, which is a small molecule, works by targeting the SMNDC1 protein and preventing it from becoming active. This could be a breakthrough in treating conditions such as Parkinson’s disease and other neurological diseases. The researchers believe that further study of the inhibitor could lead to new treatments for these devastating diseases.
source: Phys.org